Ambev
ABEV
278 hedge funds and large institutions have $5B invested in Ambev in 2021 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 104 increasing their positions, 80 reducing their positions, and 38 closing their positions.
30% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 80
24% more capital invested
Capital invested by funds: $4.04B → $5B (+$961M)
13% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 38
13% more call options, than puts
Call options by funds: $11M | Put options by funds: $9.74M
1% more funds holding
Funds holding: 276 → 278 (+2)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
0.13% less ownership
Funds ownership: 9.36% → 9.24% (-0.13%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$143M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$77.4M |
| 3 |
RL
Ruffer LLP
London,
United Kingdom
|
+$41.4M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$24.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$109M |
| 2 |
VAM
Vontobel Asset Management
New York
|
-$66.5M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$60.2M |
| 4 |
BlackRock
New York
|
-$47.2M |
| 5 |
Renaissance Technologies
New York
|
-$36.2M |
ABEV Hedge Fund Activity: Q2 2021 in Review
278 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Ambev (ABEV) for Q2 2021, worth a combined $5B — up 24% from $4.04B a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new ABEV positions and 38 closed out — a net gain of 5 holders — while 104 added to existing stakes and 80 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $143M. The largest seller was Credit Suisse, cutting an estimated $109M.
- 278 institutional investors held Ambev (ABEV) as of Q2 2021, up from 276 in Q1 2021.
- Funds reported $5B of Ambev stock for Q2 2021, up 24% quarter-over-quarter.
- 43 funds opened new Ambev positions in Q2 2021 and 38 closed out, a net change of +5 holders.
- The largest Ambev buyer in Q2 2021 was Goldman Sachs, an estimated $143M added.
- The largest Ambev seller in Q2 2021 was Credit Suisse, an estimated $109M sold.
Based on aggregated 13F filings for Q2 2021.